Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergiusz Jozwiak

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
Cellular and Molecular Neurobiology|August 10, 2006
Giant cells: contradiction to two-hit model of tuber formation?Jaroslaw Jozwiak, Sergiusz Jozwiak
Frontiers in Neurology|October 22, 2021
Editorial: Tuberous Sclerosis Complex - Diagnosis and ManagementSergiusz Jozwiak, Paolo Curatolo
Epilepsy & Behavior : E&B|February 21, 2012
Is it time to use preventative antiepileptic drug in TSC?Sergiusz Jozwiak, Katarzyna Kotulska
Cellular and Molecular Neurobiology|September 1, 2005
Giant cells: contradiction to two-hit model of tuber formation?Jaroslaw Jozwiak, Sergiusz Jozwiak
Lancet (London, England)|August 30, 2008
Tuberous sclerosisPaolo Curatolo, Roberta Bombardieri, Sergiusz Jozwiak
Epilepsia|May 3, 2006
Similarity of balloon cells in focal cortical dysplasia to giant cells in tuberous sclerosisJaroslaw Jozwiak, Katarzyna Kotulska, Sergiusz Jozwiak
Pediatrics|June 5, 2013
Possible prevention of tuberous sclerosis complex lesionsKatarzyna Kotulska, Julita Borkowska, Sergiusz Jozwiak
The Lancet. Oncology|January 8, 2008
Possible mechanisms of disease development in tuberous sclerosisJaroslaw Jozwiak, Sergiusz Jozwiak, Pawel Wlodarski
Medicinal Research Reviews|December 6, 2005
Molecular activity of sirolimus and its possible application in tuberous sclerosis treatmentJaroslaw Jozwiak, Sergiusz Jozwiak, Monika Oldak
Neuromolecular Medicine|January 5, 2006
Positive and negative regulation of TSC2 activity and its effects on downstream effectors of the mTOR pathwayJaroslaw Jozwiak, Sergiusz Jozwiak, Tomasz Grzela, et al.
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
Cellular and Molecular Neurobiology|August 10, 2006
Giant cells: contradiction to two-hit model of tuber formation?Jaroslaw Jozwiak, Sergiusz Jozwiak
Frontiers in Neurology|October 22, 2021
Editorial: Tuberous Sclerosis Complex - Diagnosis and ManagementSergiusz Jozwiak, Paolo Curatolo
Epilepsy & Behavior : E&B|February 21, 2012
Is it time to use preventative antiepileptic drug in TSC?Sergiusz Jozwiak, Katarzyna Kotulska
Cellular and Molecular Neurobiology|September 1, 2005
Giant cells: contradiction to two-hit model of tuber formation?Jaroslaw Jozwiak, Sergiusz Jozwiak
Lancet (London, England)|August 30, 2008
Tuberous sclerosisPaolo Curatolo, Roberta Bombardieri, Sergiusz Jozwiak
Epilepsia|May 3, 2006
Similarity of balloon cells in focal cortical dysplasia to giant cells in tuberous sclerosisJaroslaw Jozwiak, Katarzyna Kotulska, Sergiusz Jozwiak
Pediatrics|June 5, 2013
Possible prevention of tuberous sclerosis complex lesionsKatarzyna Kotulska, Julita Borkowska, Sergiusz Jozwiak
The Lancet. Oncology|January 8, 2008
Possible mechanisms of disease development in tuberous sclerosisJaroslaw Jozwiak, Sergiusz Jozwiak, Pawel Wlodarski
Medicinal Research Reviews|December 6, 2005
Molecular activity of sirolimus and its possible application in tuberous sclerosis treatmentJaroslaw Jozwiak, Sergiusz Jozwiak, Monika Oldak
Neuromolecular Medicine|January 5, 2006
Positive and negative regulation of TSC2 activity and its effects on downstream effectors of the mTOR pathwayJaroslaw Jozwiak, Sergiusz Jozwiak, Tomasz Grzela, et al.
Pageof 10